RG
CLVS

Redmile Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-99,485
Closed -$633K 89
2020
Q1
$633K Buy
+99,485
New +$633K 0.02% 64
2019
Q4
Sell
-3,607,800
Closed -$14.2M 80
2019
Q3
$14.2M Buy
3,607,800
+145,500
+4% +$572K 0.47% 48
2019
Q2
$51.5M Sell
3,462,300
-1,101,629
-24% -$16.4M 1.46% 22
2019
Q1
$113M Buy
4,563,929
+503,400
+12% +$12.5M 3.31% 6
2018
Q4
$72.9M Buy
4,060,529
+2,282,229
+128% +$41M 2.93% 10
2018
Q3
$52.2M Buy
1,778,300
+19,700
+1% +$579K 1.61% 21
2018
Q2
$80M Buy
+1,758,600
New +$80M 2.72% 11
2018
Q1
Sell
-1,320,027
Closed -$89.8M 76
2017
Q4
$89.8M Buy
1,320,027
+323,417
+32% +$22M 3.9% 4
2017
Q3
$82.1M Buy
996,610
+232,221
+30% +$19.1M 4.05% 5
2017
Q2
$71.6M Sell
764,389
-208,307
-21% -$19.5M 4.36% 5
2017
Q1
$61.9M Sell
972,696
-647,659
-40% -$41.2M 4.02% 5
2016
Q4
$72M Sell
1,620,355
-429,630
-21% -$19.1M 6.2% 3
2016
Q3
$73.9M Sell
2,049,985
-1,047,865
-34% -$37.8M 5.88% 4
2016
Q2
$42.5M Sell
3,097,850
-1,486
-0% -$20.4K 4.06% 8
2016
Q1
$59.5M Buy
3,099,336
+1,303,400
+73% +$25M 6.09% 3
2015
Q4
$62.9M Buy
1,795,936
+838,302
+88% +$29.3M 4.7% 6
2015
Q3
$88.1M Buy
957,634
+198,155
+26% +$18.2M 6.67% 2
2015
Q2
$66.7M Sell
759,479
-141,400
-16% -$12.4M 5.47% 4
2015
Q1
$66.9M Buy
900,879
+179,247
+25% +$13.3M 6% 2
2014
Q4
$40.4M Sell
721,632
-62,827
-8% -$3.52M 4.4% 6
2014
Q3
$35.6M Buy
784,459
+60,643
+8% +$2.75M 4.11% 3
2014
Q2
$30M Buy
723,816
+210,618
+41% +$8.72M 3.64% 7
2014
Q1
$35.5M Sell
513,198
-59,072
-10% -$4.09M 4.24% 5
2013
Q4
$34.5M Buy
572,270
+100,925
+21% +$6.08M 4.26% 2
2013
Q3
$28.6M Sell
471,345
-4,032
-0.8% -$245K 4.31% 6
2013
Q2
$31.8M Buy
+475,377
New +$31.8M 5.61% 3